Sorrento Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LATTICE CAPITAL MANAGEMENT, LLC | 08/12/2024 | 51,800 | $492 | 0.00% | 0.01% |
KLCM ADVISORS, INC. | 08/14/2024 | 30,000 | $285 | 0.00% | 0.01% |
HUNTINGTON NATIONAL BANK | 08/08/2024 | 5,001 | $49 | 0.00% | 0.00% |
Sorrento Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 38 institutional investors and hedge funds held shares of Sorrento Therapeutics, Inc.. The most heavily invested institutionals were:
Highlander Capital Management, LLC: 1,200
ETF MANAGERS GROUP, LLC: 0
B. Riley Securities, Inc.: 5.22 M
swisspartners Ltd.: 110,000
Corient Capital Partners, LLC: 14,913
American Portfolios Advisors: 4,350
0.02% of Sorrento Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.43 M shares in the last 24 months. This purchase volume represents approximately $0 in transactions.